Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001846487-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-10 | 2026-03-06+ | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.19 | -5,723 | 94.5K | -6% | -$424.6K |
| 2026-03-10 | 2026-03-07 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $74.04 | -3,314 | 98.1K | -3% | -$245.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | S | D | 2,121 | $74.22 | 101,387 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price. |
| 2 | Common | Common Stock | 2026-03-09 | S | D | 3,602 | $74.18 | 94,471 | D | — | — | (F4) The shares were sold in multiple trades at prices ranging from $73.27 to $74.81. The price reported above reflects the weighted average sales price. |
| 3 | Common | Common Stock | 2026-03-07 | F | D | 3,314 | $74.04 | 98,073 | D | — | — |